Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Methods for preventing medication-related osteonecrosis of the jaw (MRONJ) in cancer patients who have received high-dose bisphosphonate (BP) or denosumab (Dmab) have not yet been established. Tooth extraction after starting medication has been believed to be a major risk factor for MRONJ, and there...
Main Authors: | Sakiko Soutome, Saki Hayashida, Madoka Funahara, Yuki Sakamoto, Yuka Kojima, Souichi Yanamoto, Masahiro Umeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0201343&type=printable |
Similar Items
-
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients
by: Sakiko Soutome, et al.
Published: (2021-08-01) -
Clinical observation of tongue coating of perioperative patients: factors related to the number of bacteria on the tongue before and after surgery
by: Madoka Funahara, et al.
Published: (2018-12-01) -
A preliminary clinical study of segmental mandibulectomy on medication-related osteonecrosis of the jaw
by: Mitsunobu Otsuru, et al.
Published: (2022-01-01) -
Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
by: Kohei Okuyama, et al.
Published: (2021-07-01) -
Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study
by: Shoma Tsuda, et al.
Published: (2020-02-01)